The 5th Dubai Neurology Congress was successfully convened from February 21st to 23rd, 2025, at the InterContinental Dubai Festival City. This premier three-day event brought together leading neurologists, researchers, and healthcare professionals to explore the latest advancements, debate emerging protocols, and address complex challenges across the spectrum of neurological care.
The scientific program commenced on Day One with focused workshops, including an in- depth session on "Pediatric & Late-Onset MS: The Extremes of the Disease," led by Dr. Seraj Mankawi, and a critical workshop on "Life-Threatening Headache Disorders," moderated by Dr. Yasmine Kamal. The evening featured an exclusive Gala Dinner and a series of pivotal lectures. Esteemed speakers, including Prof. Peter McAllister on breaking the cycle of migraine progression and Prof. Francesco Sacca on championing care in Myasthenia Gravis, delivered cutting-edge insights that set the tone for the congress.
Day Two was marked by dynamic debates and comprehensive scientific sessions. The morning’s formal debates, moderated by Prof. Suhail Alrukn, engaged experts on contentious topics in Multiple Sclerosis and Acute Migraine management. The day progressed with dedicated sessions on Dementia, featuring notable presentations by Prof. Marwan Sabbagh on a US perspective for slowing decline and Prof. Sylvain Lehmann on blood and CSF biomarkers. Parallel sessions delved into Headache disorders and Demyelinating Diseases, with Prof. Bassem Yamout presenting on landmark articles and the evolution of B-cell therapies. The day concluded with a dedicated symposium on "Breakthroughs in Stroke Management," featuring expert dialogues on transitioning thrombolytic protocols and the importance of awareness programs.
The final day, Day Three, began with an interactive workshop on "What You Need to Know in Parkinson's Disease," led by Prof. Pierre Krystkowiak. The congress continued with formal debates on ALS and Alzheimer’s Disease, fostering rigorous discussion on therapeutic approaches. Specialized sessions on Neuromuscular disorders provided updates on new therapeutic approaches for Myasthenia Gravis and gene therapy, while the final session on Intracranial Hemorrhage covered innovative minimal invasive surgical techniques and care bundles.
Throughout the congress, the agenda facilitated a robust exchange of knowledge on precision medicine, novel biomarkers, and patient-centered treatment paradigms. The 5th Dubai Neurology Congress successfully provided an invaluable platform for collaboration, continuing to drive the field of neurology forward through education, debate, and professional networking.
